Investor interview - October 27, 2024
Do’s and don’ts for young companies on their journey to market
In a financial market that’s still catching its breath after the repeated turmoil of the past few years, many up-and-coming life science companies in the Nordics are struggling to secure investments and bring their product to market.
Investor interview - May 27, 2024
Rare diseases – A cornerstone of big pharma’s commercial offering
NLS asked Nina Rawal, Partner and Co-Head of Ventures at Trill Impact, about her perspective when it comes to financing and supporting rare disease companies. As an investor, what’s your view on rare disease companies and their potential value? “Rare disease is an area that has undergone a minor revolution in recent decades, going from […]
Investor interview - April 17, 2024
Exclusive interview: Thomas Eldered predicts 2024
Personalized medicine, weight loss remedies and new treatments for widespread ailments are among the rising areas of high interest in the biotechnology and therapeutic arenas, according to executive chairman of Flerie Invest, Thomas Eldered. Thomas Eldered talked with Nordic Life Science about the Nordic and global life science financial landscapes and Flerie’s role in funding […]
Investor interview - February 12, 2024
“Metabolic diseases will continue to attract interest”
Nordic Life Science asked Pekka Simula, Partner, Innovestor Life Science, about his predictions for 2024, including market trends, financing opportunities for SMEs and business strategy advice. What do you predict will be the dominant market trend within life sciences this year? “In the Nordics, syndication. Even while globally there’s talk about syndication being passé because […]
Investor interview - January 25, 2022
Investor interview: ”You need a global perspective”
Masha Strømme, founder of PAACS Invest, shares her advice to aspiring life science entrepreneurs looking to succeed and make a difference for patients. A French-Canadian by birth, Masha Strømme prepared for a career in research, earning a doctorate in genetics and neuroscience thanks to a Rhodes Scholarship at the University of Oxford in the United […]
Investor interview - January 19, 2022
Lars Ekman: Running R&D on both sides of the Atlantic
Lars Ekman from Gothenburg, Sweden, has more than 30 years experience in senior executive, scientific, and clinical functions within life sciences across the globe. He is today capitalizing on his extensive knowledge and sharing his experience as Executive Partner at Sofinnova Investments in the USA. Lars Ekman’s career path has taken him from Sweden to […]
